LEGAL ASPECTS OF CLINICAL TRIALS INVOLVING UNDER-AGE SUBJECTS IN RUSSIA

The article focuses on a complicated, no less pressing issue of conducting clinical trials in pediatrics. When vulnerable groups of patients are involved as subjects in clinical trials, specific ethical issues inevitably arise. When conducting clinical trials involving under-age subjects, it is nece...

Full description

Saved in:
Bibliographic Details
Main Authors: S.S. Zavidova (Author), A.A. Tolpanova (Author)
Format: Book
Published: Union of pediatricians of Russia, 2010-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_56d6a8d5cea942a4ba879da4f63d4b1d
042 |a dc 
100 1 0 |a S.S. Zavidova  |e author 
700 1 0 |a A.A. Tolpanova  |e author 
245 0 0 |a LEGAL ASPECTS OF CLINICAL TRIALS INVOLVING UNDER-AGE SUBJECTS IN RUSSIA 
260 |b Union of pediatricians of Russia,   |c 2010-03-01T00:00:00Z. 
500 |a 1727-5776 
500 |a 2500-3089 
520 |a The article focuses on a complicated, no less pressing issue of conducting clinical trials in pediatrics. When vulnerable groups of patients are involved as subjects in clinical trials, specific ethical issues inevitably arise. When conducting clinical trials involving under-age subjects, it is necessary to follow not only international standards, but, quite often, perform an in-depth analysis of national laws, taking into account law enforcement practice. Key words: clinical trials, Russian Federation laws, children. (Pediatric Pharmacology. - 2010; 7(2):25-31) 
546 |a RU 
690 |a Pediatrics 
690 |a RJ1-570 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Педиатрическая фармакология, Vol 7, Iss 2, Pp 25-31 (2010) 
787 0 |n https://pf.spr-journal.ru/jour/article/view/1162 
787 0 |n https://doaj.org/toc/1727-5776 
787 0 |n https://doaj.org/toc/2500-3089 
856 4 1 |u https://doaj.org/article/56d6a8d5cea942a4ba879da4f63d4b1d  |z Connect to this object online.